AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 140 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,000 | -18.2% | 8,823 | +68.4% | 0.00% | 0.0% |
| Q1 2022 | $22,000 | +69.2% | 5,239 | +95.4% | 0.00% | – |
| Q4 2021 | $13,000 | -18.8% | 2,681 | -11.2% | 0.00% | -100.0% |
| Q3 2021 | $16,000 | +33.3% | 3,018 | +28.0% | 0.00% | – |
| Q2 2021 | $12,000 | -47.8% | 2,357 | -29.9% | 0.00% | -100.0% |
| Q1 2021 | $23,000 | -14.8% | 3,363 | -51.7% | 0.00% | -66.7% |
| Q3 2020 | $27,000 | -63.0% | 6,961 | -66.8% | 0.00% | -90.6% |
| Q1 2020 | $73,000 | +43.1% | 20,975 | +196.0% | 0.03% | +128.6% |
| Q2 2019 | $51,000 | -60.5% | 7,085 | -22.1% | 0.01% | -72.5% |
| Q1 2019 | $129,000 | -13.4% | 9,097 | -17.2% | 0.05% | -27.1% |
| Q4 2018 | $149,000 | +2880.0% | 10,988 | +4940.4% | 0.07% | +3400.0% |
| Q3 2018 | $5,000 | -90.9% | 218 | -93.5% | 0.00% | -89.5% |
| Q2 2018 | $55,000 | – | 3,368 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $144,839,000 | 11.40% |
| Eversept Partners, LP | 4,755,480 | $32,004,380 | 2.41% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $109,116,000 | 1.27% |
| EAM Global Investors LLC | 365,719 | $2,461,000 | 0.68% |
| Signature Wealth Management Partners, LLC | 87,666 | $590,000 | 0.57% |
| Jackson Creek Investment Advisors LLC | 221,043 | $1,488,000 | 0.52% |
| Tranquilli Financial Advisor LLC | 71,414 | $481,000 | 0.39% |
| Hillsdale Investment Management Inc. | 611,200 | $4,113,000 | 0.34% |
| EAM Investors, LLC | 259,873 | $1,749,000 | 0.26% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 180,000 | $1,211,000 | 0.25% |